Volume 14, Number 10—October 2008
Research
Endemic and Epidemic Lineages of Escherichia coli that Cause Urinary Tract Infections
Amee R. Manges
, Helen Tabor, Patricia Tellis, Caroline Vincent, and Pierre-Paul Tellier
, Helen Tabor, Patricia Tellis, Caroline Vincent, and Pierre-Paul Tellier
Table 1
Antimicrobial drug resistance of Escherichia coli*
| Characteristic |
Berkeley, California, USA† |
Montréal, Québec, Canada‡ |
p value§ |
|---|---|---|---|
| Total primary E. coli |
434 |
256 |
|
| Drug | No. (%) resistant | ||
| Trimethoprim- sulfamethoxazole | 85 (20) | 36 (14) | 0.07 |
| Cephalothin | 11 (3) | 7 (3) | 0.90 |
| Ciprofloxacin | 8 (2) | 11 (4) | 0.06 |
| Nitrofurantoin | 0 | 0 | |
| Ampicillin | ND | 83 (32) | ND |
| Tetracycline | ND | 40 (16) | ND |
| Chloramphenicol | ND | 7 (3) | ND |
| Streptomycin | ND | 48 (19) | ND |
*ND, not done.
†October 1999–January 2000 and October 2000– January 2001.
‡January 2006–January 2007
§By χ2 test.
Page created: July 13, 2010
Page updated: July 13, 2010
Page reviewed: July 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.